SynthesisBMC nephrology2026

Targeted-release Budesonide (Nefecon) versus systemic glucocorticoids for IgA nephropathy: a placebo-anchored indirect treatment comparison of randomized controlled trials.

Jianbo Qing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.